Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127161771 | 12716177 | 1 | I | 2012 | 20120927 | 20160906 | 20160906 | EXP | CA-ROCHE-1140040 | ROCHE | 60.64 | YR | F | Y | 93.60000 | KG | 20160906 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127161771 | 12716177 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 680 | MG | SOLUTION FOR INFUSION | /month | |||||||
| 127161771 | 12716177 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 760 | MG | SOLUTION FOR INFUSION | ||||||||
| 127161771 | 12716177 | 3 | SS | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 127161771 | 12716177 | 4 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAY 1 AND DAY 15 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||||
| 127161771 | 12716177 | 5 | C | ENBREL | ETANERCEPT | 1 | 0 | ||||||||||||
| 127161771 | 12716177 | 6 | C | CIPRALEX | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
| 127161771 | 12716177 | 7 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127161771 | 12716177 | 8 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 1000 | MG | |||||||||
| 127161771 | 12716177 | 9 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127161771 | 12716177 | 1 | Rheumatoid arthritis |
| 127161771 | 12716177 | 3 | Product used for unknown indication |
| 127161771 | 12716177 | 4 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127161771 | 12716177 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127161771 | 12716177 | Ankle fracture | |
| 127161771 | 12716177 | Drug ineffective | |
| 127161771 | 12716177 | Ligament sprain | |
| 127161771 | 12716177 | Osteoarthritis | |
| 127161771 | 12716177 | Rheumatoid arthritis | |
| 127161771 | 12716177 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127161771 | 12716177 | 1 | 20110909 | 20130819 | 0 | |
| 127161771 | 12716177 | 2 | 20130624 | 0 | ||
| 127161771 | 12716177 | 4 | 20131105 | 0 | ||
| 127161771 | 12716177 | 8 | 20131105 | 0 | ||
| 127161771 | 12716177 | 9 | 20131105 | 0 |